Collaborative Education for Talent of the Future

Presented at: BioProcessing 2020
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • George B. and Joy Rathmann Professor in Bioprocessing and Director, Amgen Bioprocessing Center
    Biography
      Sue Behrens joined KGI as the George B. and Joy Rathmann Professor in Bioprocessing and Director of the Amgen Bioprocessing Center in 2019. Sue is also President, SB Executive Consulting, LLC providing technical and regulatory support for development and manufacturing of biologic and vaccine products. Prior to KGI, Dr. Behrens served as the Senior Director for Process Engineering at Integrated Project Solutions (IPS) in Blue Bell, PA. Within that role, she developed innovative and cost-effective solutions for complex research and manufacturing facilities within the life sciences industry. Prior to IPS, Sue held progressive leadership positions with Merck & Co., Inc. Starting her career in Technical Operations supporting sterile API and large-scale fermentation operations, she held positions of increasing responsibility in Research & Development, as well as Process design for capital projects. Subsequently, she oversaw Sterile Process Technology & Engineering functions at Merck's largest site, including the launch of four new vaccine products. Ultimately, as Senior Director, Biologics Manufacturing Science & Commercialization, Sue provided manufacturing technology direction for multiple biologics development and manufacturing sites worldwide. Sue Behrens earned her PhD in Chemical Engineering from the University of California, Berkeley, and a Bachelor of Science in Chemical Engineering from the University of Michigan. She maintains affiliations with the International Society of Pharmaceutical Engineers, Women in Bio, and BioProcess International.

    Abstract

    Strong performance for a Facility of the Future for the Life Sciences industry requires more than optimal manufacturing process development and facility design.  The sector encompasses a diverse set of products, technologies and platforms which require application of multi-disciplinary skills.  Successful organizations must attract technical and operational leaders with a combination of science, engineering, information and business expertise.  Company growth can be hindered by availability of sufficiently skilled candidates and the implementation of higher levels of technology to achieve Pharm 4.0 is expected to further constrain an already limited talent pool.   It is critical to focus on selecting the right employees from the start, while continuing to build competences through internal and external training opportunities.  Many candidates begin their career with a strong foundation which can be rapidly built upon to ensure success in industry.  This presentation will describe collaborative opportunities for talent development for the industry, including academic partners (e.g. KGI Amgen Bioprocessing Center) and programs funded by federal (e.g. NIIMBL) or state (e.g. BTEC) grants.

    Learning Objectives:

    1. Understand the current state of talent availability for Biopharmaceutical Manufacturing

    2. Define the requirements of Pharma 4.0 and impact on demand for talent

    3. Recognize shift in education and training to bridge to success in a digitized manufacturing environment


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    Loading Comments...
    Show Resources
    Attendees
    • See more